MedPath

Enhancing Children's Cognitive Function and Achievement Through Carotenoid Consumption

Not Applicable
Recruiting
Conditions
Macular Pigmentation
Cognitive Change
Achievement
Interventions
Dietary Supplement: Placebo control
Dietary Supplement: Active supplement
Registration Number
NCT05177679
Lead Sponsor
University of Illinois at Urbana-Champaign
Brief Summary

The aim of this study is to test the casual relationship between carotenoid supplementation, cognitive function, and achievement over a school-year. The central hypothesis is that, relative to the waitlist placebo group, children receiving the carotenoid supplement will exhibit greater gains in cognitive function and achievement.

Detailed Description

This clinical trial will be a randomized placebo-controlled double-blind trial to examine the effects of carotenoid supplementation on cognitive control, hippocampal-dependent relational memory, and academic achievement among pre-adolescents over one school year (i.e. 9-months).

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
288
Inclusion Criteria
  • Child assent and parent/guardian consent
  • 8-10 years of age
  • No lutein supplementation within 6-months prior to enrollment (exception of multivitamins containing less than 1 mg lutein/day)
  • Absence of learning disability (parent-reported)
  • Tanner scale score ≤ 2
  • 20/20 or corrected vision
Exclusion Criteria
  • Non-assent of child or non-consent of guardian
  • Above/below 8-10 years of age
  • Lutein supplementation within 6-months prior to enrollment (including multivitamins containing more than 1 mg lutein/day)
  • Identified learning disability (parent-reported)
  • Tanner scale score > 2
  • Not 20/20 or uncorrected vision

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Placebo ControlPlacebo controlThe placebo control group participants will be asked to consume a placebo supplement for 9 months.
Active SupplementActive supplementThe active supplementation group participants will be asked to consume a daily carotenoid supplement for 9 months.
Primary Outcome Measures
NameTimeMethod
Hippocampal-dependent Relational memory9 months (Baseline vs Follow-up)

Spatial memory task accuracy

Attentional Accuracy9 months (Baseline vs Follow-up)

Changes in accuracy (%) between groups using a computerized flanker task.

Composite Academic Achievement9 months (Baseline vs Follow-up)

Kaufman Test of Academic and Educational Achievement II (KTEA III) composite or comprehensive academic achievement score. The scores are standard scores with a minimum score of 40 and a maximum score of 160 where a higher score indicates a better outcome.

Attentional Reaction Time9 months (Baseline vs Follow-up)

Changes in reaction time (ms) between groups using a computerized flanker task.

Secondary Outcome Measures
NameTimeMethod
Macular Pigment Optical Density9 months (Baseline vs Follow-up)

Changes in Macular Pigment Optical Density (log units) between groups using a macular densitometer.

Attentional Resource Allocation9 months (Baseline vs Follow-up)

Changes in P3 event related potential amplitude (microvolts) between groups using a computerized flanker task.

Written Language9 months (Baseline vs Follow-up)

Assessed as Written Language subtest standard scores on the KTEA III. The scores are standard scores with a minimum score of 40 and a maximum score of 160 where a higher score indicates a better outcome.

Reading Fluency9 months (Baseline vs Follow-up)

Assessed as Reading Fluency subtest standard scores on the KTEA III. The scores are standard scores with a minimum score of 40 and a maximum score of 160 where a higher score indicates a better outcome.

Attentional Processing Speed9 months (Baseline vs Follow-up)

Changes in P3 event related potential latency (ms) between groups using a computerized flanker task.

Math9 months (Baseline vs Follow-up)

Assessed as Mass subtest standard scores on the KTEA III. The scores are standard scores with a minimum score of 40 and a maximum score of 160 where a higher score indicates a better outcome.

Reading9 months (Baseline vs Follow-up)

Assessed as Reading subtest standard scores on the KTEA III. The scores are standard scores with a minimum score of 40 and a maximum score of 160 where a higher score indicates a better outcome.

Trial Locations

Locations (1)

University of Illinois Urbana-Champaign

🇺🇸

Urbana, Illinois, United States

© Copyright 2025. All Rights Reserved by MedPath